Emmaus Life Sciences, Inc Alternatives & Competitors

12 companies similar to Emmaus Life Sciences, Inc — Improving the lives of people with rare disease.

Alexion Pharmaceuticals, Inc.

Transforming Lives, Every Day.

5137 Acquired $39.02B

Boston, United States

Charco

Charco is a medtech start-up working on a system for people with Parkinson's to improve th...

73 Seed $7.40M

Cambridge, United Kingdom

Biotechnology Health Care

RNAimmune

Novel medicine for all through mRNA therapeutics.

9 Series A $39.35M

Gaithersburg, United Stat...

Biotechnology Health Care +1

Amgen

#WeareBiotech

40947 IPO $32.51B

Thousand Oaks, United Sta...

Biotechnology Health Care +2

Track all Emmaus Life Sciences, Inc competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

uniQure

Transforming the lives of patients through gene therapy

309 IPO $1.12B

Amsterdam, The Netherland...

Biotechnology Pharmaceutical

Corstasis Therapeutics

Advancing Options for Patients Suffering from Edema Associated with Congestive Heart Failu...

10 Unknown

Henderson, United States

Laminar Pharma

Biopharmaceutical company performing discovery, rational design and initial clinical devel...

39 Unknown $18.20M

Spain

Biotechnology Life Sciences +1

Stoparkinson Healthcare Systems Inc

Developing a wearable device for alleviation of Parkinson disease symptoms

San Mateo, United States

Health Care Manufacturing +1

Latina Pharma Spa

Experts Taking Care!

142

Italy

Manufacturing Pharmaceutical

AAVantgarde

Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...

70 Series A

Biotechnology Health Care +1

Yaqrit

The Liver Disease Company

13 Convertible Note $15.70M

London, United Kingdom

Biotechnology Health Care +3

Orca Bio

Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.

327 Series D $192.00M

Menlo Park, United States

Health Care Pharmaceutical

About Emmaus Life Sciences, Inc

Improving the lives of people with rare disease.

Services

Development and commercialization of pharmaceutical treatments, Telehealth for prescription management and patient support, Conducting clinical trials and medical research

Target Customers

Patients with sickle cell disease, Patients with diverticulosis, Healthcare professionals and providers, Global health regulatory bodies

Taxonomy

Biopharmaceuticals, Rare Diseases, Orphan Diseases, Sickle Cell Disease, L-glutamine Treatment, Phase 3 Clinical Trials, Sickle Cell Anemia, Sickle ß0-thalassemia, Short Bowel Syndrome, FDA Orphan Drug Designation, Fast Track Designation, Pharmaceutical Grade Treatments, Genetic Disorders

Business Model

B2C, B2B, D2C

Revenue Model

Product Sales, Licensing

Frequently Asked Questions

Top alternatives to Emmaus Life Sciences, Inc include Alexion Pharmaceuticals, Inc., Charco, RNAimmune, Amgen, uniQure. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Emmaus Life Sciences, Inc based on industry overlap, target customers, and business model.

Improving the lives of people with rare disease.

Don't just read about them. Follow them.

BounceWatch watches Emmaus Life Sciences, Inc and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Emmaus Life Sciences, Inc Profile Alexion Pharmaceuticals, Inc. Alternatives Charco Alternatives RNAimmune Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Emmaus Life Sciences, Inc on 11 Mar 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.